维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="ParratE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	In vitro evaluation of inflammatory cell response after CF4 plasma surface modification of poly (methyl methacrylate) intraocular lenses显示文摘	Eloy R Parrat D Duc TM	1993	J Cataract Refract Surg1993，19，：	1
2	Cytokeratins as serum markers in lung cancer:a comparison of CYFRA21-1 and TPA显示文摘	Pujol J L Grenier J Parrat E	1996	Am J Respir Crit Care Med1996，154，31：	1
3	Cytokeratins as serum mark- ers in lung eaneer: a comparison of CYFRA 21-1 and TPS显示文摘	Pujol JL Grenier J Parrat E	1996	Am J Respir Crit Care Med1996，154，3：	1
4	Cytokeratins as Serum markers in lung Cancer :a Comparison of CYFRA21-1 and TPS显示文摘	Pujol JL Grenirt J Parrat E	1996	Am J Respir Crit Care Med1996，1549，31：	1
5	Cytokeratins as serum markers in lung cancer:a comparison of CYFRA 21-1 and TPS显示文摘	Pujol JL Grenier J Parrat E	1996	Am J Respir CritCare Med1996，154，：	1
6	Cytokeratinsasserummarkersinlungcancer:acomparisonofCYFRA21-1andTPS显示文摘	PujolJL GrenierJ ParratE etal	1996	AmJReapirCritCareMed,1996;154:7251996，15，：	1
7	Protective effects of preconditioning of the ischemic myoeardium involve cyclo-oxygenase products显示文摘	Ghosh S Standen L Parrat JR	2000	Cardiovasc Res2000，45，2：	1
8	Protection of the heart by ischemic preconditioning and possibilities for pharmacological exploitation 显示文摘	Parrat J	1994	Trends in Pharmacological Science1994，15，：	1
9	查看详情显示文摘	Parrat L G		0，，：	1
10	Preconditioning of the ischemic myocardium: involvement of the L-arginine nitric oxide pathway显示文摘	VEGH A SZEKERES L PARRAT J	1992	Br J Pharmacal1992，107，3：	1
11	3zsi in precipitation: evaluation of temporal and spatial variation and as dating tool for glacial ice 显示文摘	Morgenstern U Toylor C B Parrat Y	1996	Earth and Planetary Science Letters1996，144，：	1
12	In vitro evaluation of inflammation cell re-sponseafter CF4 plasmasurface modification of poly (melthyl-methacrylate) intraocular lenses显示文摘	Eloy R Parrat D		0，，：	1
13	Cytokeratins as serum markers in lung cancer: a comparisonof CYFRA21-1 and TPS显示文摘	Pujol J L Grenier J Parrat E	1996	Am J Reapir Crit Care Med1996，154，31：	1
14	Cytokeratins as serum markers in lung cancer:a comparison of CYFRA 21-1 and TPS显示文摘	Pujol J L Grenier J Parrat E	1996	Am J Respir Crit Care Med1996，154，31：	1
15	Preconditioning of the ischemic myocardium; involvement of the L-arginine nitric oxide pathway 显示文摘	Vegh A Szekeres L Parrat J	1992	Br J Pharmacal1992，107，3：	1
16	in lung cancer, a d TPS 显示文摘	Puiol J L Grenier J Cytokeratins as Serum markers comparison of CYFRA21- 1 an Parrat E	1996	Am J Respir Crit Care Med1996，154，：	1
17	Cytokeratins as serum markers in lung cancer:a comparison of CYFRA 21-1 and TPS显示文摘	Grenier J Parrat E	1996	Am J Respir Crit Care Med1996，154，31：	1
18	Cytokeratins as ser- um markers in lung cancer : a comparison of CYFRA21-1 and TPS显示文摘	Pujol JL Grenier J Parrat E	1996	Am J Respir Crit Care Med1996，154，31：	1
19	Cytokeratins as serum markers in lung cancer:a comparison of CYFRA 21.1 and TPS显示文摘	Pujol JL Grenier J Parrat E		0，，：	1
20	Cytokeratins as serum markers in lung cancer:a comparison of CYFRA 21-1 and TPS显示文摘	Pujol JL Grenier J Parrat E	1996	Am J Respir Crit Care Med1996，154，31：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示